Re : Thomas Powles, Robert A. Huddart, Tony Elliott, et al. Phase III, Double-blind, Randomized Trial that Compared Maintenance Lapatinib versus Placebo after First-line Chemotherapy in Patients with Human Epidermal Growth Factor Receptor 1/2-positive Metastatic Bladder Cancer. J Clin Oncol 2017;35:48-55. Knowing HER2 Status is Not Enough: A Molecular Subtype Approach to Bladder
(2017) In European Urology 72(5). p.135-136
Please use this url to cite or link to this publication:
https://lup.lub.lu.se/record/757bcafc-c1c8-4ec6-85f1-10a6da05441c
- author
- Eriksson, Pontus LU ; Sjödahl, Gottfrid LU and Liedberg, Fredrik LU
- organization
- publishing date
- 2017
- type
- Contribution to journal
- publication status
- published
- subject
- in
- European Urology
- volume
- 72
- issue
- 5
- pages
- 135 - 136
- publisher
- Elsevier
- external identifiers
-
- scopus:85019740982
- pmid:28571886
- wos:000412685300009
- ISSN
- 0302-2838
- DOI
- 10.1016/j.eururo.2017.05.027
- language
- English
- LU publication?
- yes
- id
- 757bcafc-c1c8-4ec6-85f1-10a6da05441c
- date added to LUP
- 2017-06-16 12:41:11
- date last changed
- 2024-02-29 16:53:12
@misc{757bcafc-c1c8-4ec6-85f1-10a6da05441c,
author = {{Eriksson, Pontus and Sjödahl, Gottfrid and Liedberg, Fredrik}},
issn = {{0302-2838}},
language = {{eng}},
number = {{5}},
pages = {{135--136}},
publisher = {{Elsevier}},
series = {{European Urology}},
title = {{Re : Thomas Powles, Robert A. Huddart, Tony Elliott, et al. Phase III, Double-blind, Randomized Trial that Compared Maintenance Lapatinib versus Placebo after First-line Chemotherapy in Patients with Human Epidermal Growth Factor Receptor 1/2-positive Metastatic Bladder Cancer. J Clin Oncol 2017;35:48-55. Knowing HER2 Status is Not Enough: A Molecular Subtype Approach to Bladder}},
url = {{http://dx.doi.org/10.1016/j.eururo.2017.05.027}},
doi = {{10.1016/j.eururo.2017.05.027}},
volume = {{72}},
year = {{2017}},
}